ID   PMDC05
AC   CVCL_5G47
DR   Wikidata; Q54947630
RX   PubMed=19443030;
RX   PubMed=25075025;
WW   Info; -; -; https://web.archive.org/web/20160706131224/http://www.clg.niigata-u.ac.jp:80/~matak/eng/resmat12.pdf
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=19443030).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
RX   PubMed=19443030; DOI=10.1016/j.leukres.2009.03.047;
RA   Narita, Miwako
RA   Watanabe, Norihiro
RA   Yamahira, Akie
RA   Hashimoto, Shigeo
RA   Tochiki, Nozomi
RA   Saitoh, Anri
RA   Kaji, Masami
RA   Nakamura, Takeshi
RA   Furukawa, Tatsuo
RA   Toba, Ken
RA   Fuse, Ichiro
RA   Aizawa, Yoshifusa
RA   Takahashi, Masuhiro
RT   "A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability
RT   to secrete IFN-alpha by stimulation via Toll-like receptors and
RT   present antigens to naive T cells.";
RL   Leuk. Res. 33:1224-1232(2009).
//
RX   PubMed=25075025;
RA   Yamahira, Akie
RA   Narita, Miwako
RA   Iwabuchi, Minami
RA   Uchiyama, Takayoshi
RA   Iwaya, Shunpei
RA   Ohiwa, Rie
RA   Nishizawa, Yoshinori
RA   Suzuki, Takafumi
RA   Yokoyama, Yusaku
RA   Hashimoto, Shigeo
RA   Takizawa, Jun
RA   Sone, Hirohito
RA   Takahashi, Masuhiro
RT   "Activation of the leukemia plasmacytoid dendritic cell line PMDC05 by
RT   Toho-1, a novel IDO inhibitor.";
RL   Anticancer Res. 34:4021-4028(2014).
//